Precision recruitment for high-risk participants in a COVID-19 cohort study

被引:0
|
作者
Mezlini, Aziz M. [1 ]
Caddigan, Eamon [1 ]
Shapiro, Allison [1 ]
Ramirez, Ernesto [1 ]
Kondow-McConaghy, Helena M. [2 ]
Yang, Justin [3 ]
DeMarco, Kerry [3 ]
Naraghi-Arani, Pejman [3 ]
Foschini, Luca [1 ]
机构
[1] Evidat Hlth Inc, 63 Bovet Rd 146, San Mateo, CA 94402 USA
[2] Oak Ridge Inst Sci & Educ, 1299 Bethel Valley Rd, Oak Ridge, TN 37830 USA
[3] US Dept Hlth & Human Serv, Biomed Adv Res & Dev Author, Off Assistant Secretary Preparedness & Response, 200 Independence Ave, Washington, DC 20201 USA
关键词
COVID-19; Clinical trials; Risk modeling;
D O I
10.1016/j.conctc.2023.101113
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Studies for developing diagnostics and treatments for infectious diseases usually require observing the onset of infection during the study period. However, when the infection base rate incidence is low, the cohort size required to measure an effect becomes large, and recruitment becomes costly and prolonged. We developed a model for reducing recruiting time and resources in a COVID-19 detection study by targeting recruitment to highrisk individuals. Methods: We conducted an observational longitudinal cohort study at individual sites throughout the U.S., enrolling adults who were members of an online health and research platform. Through direct and longitudinal connection with research participants, we applied machine learning techniques to compute individual risk scores from individually permissioned data about socioeconomic and behavioral data, in combination with predicted local prevalence data. The modeled risk scores were then used to target candidates for enrollment in a hypothetical COVID-19 detection study. The main outcome measure was the incidence rate of COVID-19 according to the risk model compared with incidence rates in actual vaccine trials. Results: When we used risk scores from 66,040 participants to recruit a balanced cohort of participants for a COVID-19 detection study, we obtained a 4- to 7-fold greater COVID-19 infection incidence rate compared with similar real-world study cohorts. Conclusion: This risk model offers the possibility of reducing costs, increasing the power of analyses, and shortening study periods by targeting for recruitment participants at higher risk.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19
    Horga, Arantxa
    Kuritzkes, Daniel R.
    Kowalczyk, John J.
    Pietropaolo, Keith
    Belanger, Bruce
    Lin, Kai
    Perkins, Kristen
    Hammond, Janet
    [J]. FUTURE VIROLOGY, 2023, 18 (08) : 489 - 500
  • [2] PRECISION DOSING AND SAFETY OF ENOXAPARIN IN HIGH-RISK PATIENTS WITH COVID-19
    Bonderski, Veronica
    DeMott, Joshua
    Whittier, William
    Panos, Nicholas
    Rodby, Roger
    Jain, Shivi
    Gashti, Casey
    Gurnani, Payal
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 109 - 109
  • [3] Preliminary assessment of COVID-19 serological situation in a high-risk cohort
    Cornio, Alessandro Roberto
    Bordino, V.
    Meddis, D.
    Garlasco, J.
    Marengo, N.
    Vicentini, C.
    Di Tommaso, S.
    Giacomuzzi, M.
    Memoli, G.
    Zotti, C. M.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31
  • [4] Weight Gain during the COVID-19 Pandemic in a High-risk Cohort of Children
    Beck, Amy
    Huang, John
    Lendzion, Lauren
    Fernandez, Alicia
    Martinez, Suzanna
    [J]. OBESITY, 2021, 29 : 45 - 46
  • [5] Dengue and Covid-19, a high-risk association
    Buxeraud, Jacques
    [J]. ACTUALITES PHARMACEUTIQUES, 2020, 59 (597): : 7 - 7
  • [6] Ramipril in High-Risk Patients With COVID-19
    Amat-Santos, Ignacio J.
    Santos-Martinez, Sandra
    Lopez-Otero, Diego
    Nombela-Franco, Luis
    Gutierrez-Ibanes, Enrique
    Del Valle, Raquel
    Munoz-Garcia, Erika
    Jimenez-Diaz, Victor A.
    Regueiro, Ander
    Gonzalez-Ferreiro, Rocio
    Benito, Tomas
    Sanmartin-Pena, Xoan Carlos
    Catala, Pablo
    Rodriguez-Gabella, Tania
    Delgado-Arana, Jose Raul
    Carrasco-Moraleja, Manuel
    Ibanez, Borja
    San Roman, J. Alberto
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (03) : 268 - 276
  • [7] Rethinking high-risk groups in COVID-19
    Vishnevetsky, Anastasia
    Levy, Michael
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
  • [8] COVID-19 and smoking: a high-risk association
    Oliveira Silva, Andre Luiz
    Moreira, Josino Costa
    Martins, Stella Regina
    [J]. CADERNOS DE SAUDE PUBLICA, 2020, 36 (05):
  • [9] Mortality of high-risk orthopaedic oncology patients during the COVID-19 pandemic: A prospective cohort study
    Stevenson, Jonathan D.
    Evans, Scott
    Morris, Guy
    Tillman, Roger
    Abudu, Adesegun
    Jeys, Lee
    Parry, Michael
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (06) : 1027 - 1030
  • [10] Maternal and neonatal outcomes of COVID-19 in a high-risk pregnant cohort with and without HIV
    de Waard, L.
    Langenegger, E.
    Erasmus, K.
    van der Merwe, T.
    Olivier, S. E.
    du Toit, N.
    Paulsen, C.
    Nkangana, N.
    van Niekerk, M.
    Moodley, A.
    Schell, S.
    Taljaard, J.
    Botha, M. H.
    Dramowski, A.
    Cluver, C. A.
    Bekker, A.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2021, 111 (12): : 1174 - 1180